SUBSCRIBE
SUBSCRIBE

Thrive Earlier Detection

NEWS
Thrive Earlier Detection was acquired by Exact Sciences in 2021.
Photo courtesy of Exact Sciences
Deals
Exact Sciences to Acquire Thrive in Deal Valued at $2.15 Billion
The deal, which is worth up to $2.15 billion, is expected to close in the first quarter of 2021 and is subject to regulatory approval.
October 27, 2020
 · 
3 min read
 · 
Krystle Vermes
Business
BioSpace Movers & Shakers, Oct. 2
Biopharma and life sciences companies strengthen their leadership teams and boards with these Movers & Shakers.
October 1, 2020
 · 
8 min read
 · 
Alex Keown
Genetown
Thrive Brings in $257 Million More to Advance Cancer Liquid Biopsy Assay
Thrive Earlier Detection, headquartered in Cambridge, Massachusetts, closed on a Series B financing worth $257 million.
July 29, 2020
 · 
3 min read
 · 
Mark Terry
Business
Thrive’s Blood Test IDs Cancers More than Twice That of Traditional Testing
The study was run by Johns Hopkins University and Geisinger Health, testing more than 10,000 women with no previous history of cancer.
April 29, 2020
 · 
3 min read
 · 
Mark Terry
Business
Top Life Sciences Startups to Watch in 2020
BioSpace is proud to present its NextGen Bio “Class of 2020,” a list of up-and-coming life science companies in North America that launched no earlier than mid-2018.
January 3, 2020
 · 
13 min read
 · 
Mark Terry
AWARDS
  • NextGen Class of 2020
JOBS
IN THE PRESS
Deals
Exact Sciences To Acquire Thrive Earlier Detection, Becoming A Leader In Blood-Based, Multi-Cancer Screening
October 27, 2020
 · 
15 min read
Business
Thrive Earlier Detection Strengthens Leadership Team
September 30, 2020
 · 
4 min read
Business
Thrive Earlier Detection Strengthens Team with Key Appointments and Promotion
March 17, 2020
 · 
3 min read